Abstract
Esophageal cancer is ranked sixth in mortality and classified as the eighth most common cause of cancer [30]. It is classified by two main histological types squamous-cell carcinoma and adenocarcinoma. Both types of malignancy differ in regard to incidence, etiology, risk factors, and population affected. Esophageal squamous-cell carcinoma has been associated with smoking, heavy alcohol use, red meat consumption, hot beverage drinking, poor oral health, low intake of fresh fruits and vegetables, and low socioeconomic status. Obesity, gastroesophageal reflux disease, and Barrett’s esophagus have been recognized as high-risk factors for adenocarcinoma of the esophagus. There are several conditions and lesions that are considered premalignant and may lead to the development of esophageal carcinoma.
Esophageal cancer is typically three to four times more common among males than in females and slightly deadlier in men than women. The most common presenting symptom in esophageal cancer is dysphagia. The majority of patients do not present with premalignant or early-stage disease but with advanced locoregional and metastatic disease. Proper histopathological diagnosis and staging are crucial in determining the adequate management of patients with esophageal cancer. There are a wide variety and combination of treatments including chemotherapy, radiation, endoscopic procedures, and surgery. Major morbidity after esophagectomy can be up to 65%. Anastomotic leak and pulmonary complications are among the most reported complications. Esophagogastric anastomotic leak accounts for 40% of postoperative fatalities after esophagectomy. The incidence is 4–17%, and the etiology is multifactorial. The 5-year survival rate for patients able to undergo resection is 47%.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aday U, Gündeş E, Ali Çetin D, et al. Long-term evolution of squamous-cell cancer in Plummer-Vinson syndrome. Przegla̜d Gastroenterologiczny. 2017;12(3):226–8.
Ajani JA, D’Amico TA, Almhanna K, et al. Esophageal and esophagogastric junction cancers, version 1.2015: clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2015;13(2):194–227.
American Cancer Society (2018) Cancer facts & figures 2018. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2018.html
Blum MA, Taketa T, Sudo K, et al. Chemoradiation for esophageal cancer. Thorac Surg Clin. 2013;23:551–8.
Colwell EM, Encarnacion CO, Rein LE, et al. Atrial fibrillation after transhiatal esophagectomy with transcervical endoscopic esophageal mobilization: one institution’s experience. J Cardiothorac Surg. 2018;13:73.
Contini S, Scarpignato C. Caustic injury of the upper gastrointestinal tract: a comprehensive review. World J Gastroenterol. 2013;19(25):3918–30.
Crumley S, Schraag S. The role of local anaesthetic techniques in ERAS protocols for thoracic surgery. J Thorac Dis. 2018;10(3):1998–2004. https://doi.org/10.21037/jtd.2018.02.48.
Cuellar SL, Carter BW, Macapiinlac HA, et al. Clinical staging of patients with early esophageal adenocarcinoma: does PDG-PET/CT have a role? J Thorac Oncol. 2014;9(8):1202–6.
D’Amico TA. Mckeown esophagogastrectomy. J Thorac Dis. 2014;6(Suppl 3):S322–4.
Ellis A, Risk JM, Maruthappu T, et al. Tylosis with oesophageal cancer: diagnosis, management and molecular mechanisms. Orphanet J Rare Dis. 2015;10: 126.
Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–52.
Herbella FA, Dubecz A, Patti MG. Esophageal diverticula and cancer. Dis Esophagus. 2012;25(2):153–8.
Hikage M, Kamei T, Nakano T, Abe S, Katsura K, Taniyama Y, Sakurai T, Teshima J, Ito S, Niizuma N, Okamoto H, Fukutomi T, Yamada M, Maruyama S, Ohuchi N. Impact of routine recurrent laryngeal nerve monitoring in prone esophagectomy with mediastinal lymph node dissection. Surg Endosc. 2017;31(7): 2986–96.
Hofstetter WL. Salvage esophagectomy. J Thorac Dis. 2014;6(3):341–9.
Kim H, Park H, Choi HS, et al. Retention esophagitis as a significant clinical predictor of progression of esophageal cancer in achalasia. Clin Endosc. 2018;51(2):161–6.
Lv L, Hu W, Ren Y, et al. Minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a meta-analysis. Onco Targets Ther. 2016;9:6751–62.
Ma G-W, Situ D-R, Ma Q-L, et al. Three-field vs two-field lymph node dissection for esophageal cancer: a meta-analysis. World J Gastroenterol. 2014;20(47): 18022–30.
Miao L, Zhang Y, Hu H, Ma L, Shun Y, Xiang J, Chen H. Incidence and management of chylothorax after esophagectomy. Thorac Cancer. 2015;6(3):354–8.
Napier KJ, Scheerer M, Misra S. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol. 2014;6(5):112–20.
Ohi M, Toiyama Y, Omura Y, et al. Risk factors and measures of pulmonary complications after thoracoscopic esophagectomy for esophageal cancer. Surg Today. 2018; https://doi.org/10.1007/s00595-018-1721-0. [Epub ahead of print]
Pennathur A, Zhang J, Chen H, et al. The “best operation” for esophageal cancer? Ann Thorac Surg. 2010;89(6):S2163–7.
Rice TW, Patil DT, Blackstone EH. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg. 2017;6(2):119–30.
Sakatoku Y, Fukaya M, Fujieda H, et al. Tracheoesophageal fistula after total resection of gastic conduit for gastro-aortic fistula due to gastric ulcer. Surg Case Rep. 2017; https://doi.org/10.1186/s400792-017-0371-6.
Shridhar R, Takahashi C, Huston J, et al. Anastomotic leak and neoadjunctive chemotherapy in esophageal cancer. J Gastrointest Oncol. 2018;9(5):894–902.
Svetanoff WJ, McGahan R, Singhal S, et al. Quality of life after esophageal resection. Patient Relat Outcome Meas. 2018;9:137–46.
Torre LA, Siegel RL, Ward EM, et al. Global cancer incidence and mortality rates and trends – an update. Cancer Epidemiol Biomarkers Prev. 2016;25(1): 16–27.
Van Workum F, Berkelmans GH, Klarenbeek BR, et al. McKeown or Ivor Lewis totally minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal junction: systematic review and meta-analysis. J Thorac Dis. 2017;9(Suppl 8):S826–33.
Veelo DP, Geerts BF. Anaesthesia during oesophagectomy. J Thorac Dis. 2017;9(Suppl 8):S705–12.
Yoshida N, Watanabe M, Baba Y, Iwagami S, Ishimoto T, Iwatsuki M, Sakamoto Y, Miyamoto Y, Ozaki N, Baba H. Risk factors for pulmonary complications after esophagectomy for esophageal cancer. Surg Today. 2014;44(3):526–32.
Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol. 2013;19(34):5598–606.
Zhou C, Ma G, Li X, et al. Is minimally invasive esophagectomy effective for preventing anastomotic leakages after esophagectomy for cancer? A systematic review and meta-analysis. World J Surg Oncol. 2015;13:269.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Puskac, M.M., Hetz, R.A. (2020). Thoracic Surgery and Esophagectomy. In: Nates, J., Price, K. (eds) Oncologic Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-74588-6_166
Download citation
DOI: https://doi.org/10.1007/978-3-319-74588-6_166
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74587-9
Online ISBN: 978-3-319-74588-6
eBook Packages: MedicineReference Module Medicine